Fischer Medical Ventures Ltd Collaborated With Malaysia”s Health Digital Technologies

On July 24, 2024, Fischer Medical Ventures Ltd, formerly Fischer Chemic Limited, announced that it is expanding its investment in Health Digital Technologies (HDT). They join existing investors like Samsung Ventures and Malaysia’s Khazanah, through MTDC. This investment aims to extend HDT’s teleconsultation and e-prescription service, DoctorOnCall, beyond Malaysia.

Overview of DoctorOnCall’s Services and Reach

DoctorOnCall is a leading digital healthcare platform in Malaysia. It offers a wide range of services including teleconsultations, an online pharmacy, a health services marketplace, insurance solutions, and corporate medical concierge services. The platform connects with over 500 GP clinics, has more than 1.9 million registered users, and handles over 20 million visits annually. It provides an easy-to-use interface for accessing healthcare services and managing medical needs.

Fischer MV’s Role and Innovations in Medical Technologies

Fischer Medical Ventures Ltd (Fischer MV) specialises in providing affordable and accessible medical diagnostic and imaging technologies. They use advanced innovations and AI-powered software to improve healthcare. Fischer MV is the first company in India to manufacture high-quality MRI systems and has a wide range of breakthrough diagnostic solutions. They plan to expand their telehealth services globally with HDT.

Key Features of HDT’s Digital Health Exchange (DHX) Platform

HDT’s main innovation is the Digital Health Exchange (DHX) platform. This platform collects healthcare services from different providers, making it easier to integrate services across the sector. By using technology, HDT connects patients, healthcare providers, and insurers, setting new standards for accessibility, efficiency, and quality in digital healthcare.

HDT’s Focus on Security and User Convenience

HDT prioritises security and user convenience with easy KYC processes and strong verification protocols. Users can quickly select medications, consult with doctors, or manage health packages with just 3 clicks. HDT’s business strategy focuses on providing HealthTech solutions to hospitals, life sciences companies, and a large insurance and corporate network, including Allianz, AIA, FWD, Generali, Etiqa, Great Eastern, and Prudential. Their focus on regulatory compliance, data privacy, and security earned them a spot on Forbes Asia’s “100 to Watch” list.

Recent HDT Contracts and Global Expansion

HDT has won contracts with Malaysia’s largest Telco, CelcomDigi, to provide digital healthcare services to over 14,000 independent GPs, expanding DoctorOnCall’s network for home care and introducing a “Dengue Test” through their GP network. Building on the success of DoctorOnCall, HDT is also expanding into Southeast Asia, with new contracts in Saudi Arabia and ongoing growth in Singapore and Indonesia, benefiting from increased medical tourism in Malaysia.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.